Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:   (1) Percentage is based on 811,418,179 shares of Class A Common Stock, par value $0.0001 per share, outstanding as reported in Medline Inc.'s Final Prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025, following the underwriters' exercise in full of their option to purchase additional shares of Class A Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) Percentage is based on 811,418,179 shares of Class A Common Stock, par value $0.0001 per share, outstanding as reported in Medline Inc.'s Final Prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025, following the underwriters' exercise in full of their option to purchase additional shares of Class A Common Stock.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) Percentage is based on 811,418,179 shares of Class A Common Stock, par value $0.0001 per share, outstanding as reported in Medline Inc.'s Final Prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025, following the underwriters' exercise in full of their option to purchase additional shares of Class A Common Stock.


SCHEDULE 13G



 
GIC Private Limited
 
Signature:/s/ Jo-Ann Khor Hey Ming
Name/Title:Jo-Ann Khor Hey Ming/Senior Vice President
Date:12/29/2025
 
Signature:/s/ Lim Bee Peng
Name/Title:Lim Bee Peng/Senior Vice President
Date:12/29/2025
 
GIC Special Investments Private Limited
 
Signature:/s/ Sensen Lin
Name/Title:Sensen Lin/Authorized Signatory for GIC SI
Date:12/29/2025
 
Hux Investment Pte. Ltd.
 
Signature:/s/ Suresh Bala
Name/Title:Suresh Bala/Director
Date:12/29/2025